Allergan says it stands by statements on Valeant

BOSTON, Oct 21 (Reuters) - Allergan Inc said on Tuesday that it believes there is no evidence to support Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management's claims that its chief executive officer spearheaded a campaign to spread misinformation about Valeant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.